Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

Subjects:

Carbidopa decreases number of pathogenic CD4+ T cells during EAE. by Huabin Zhu (594342)

Summary of the expected results with corresponding hypotheses. by Marcel F. Hinss (14675457)

Subjects:

The demographics questionnaire includes questions about age, education, gender and employment. by Marcel F. Hinss (14675457)

Subjects:

RTs (in ms, bars) and ACC (in%, line) across time points, with 95% confidence interval. by Marcel F. Hinss (14675457)

Subjects:

RTs (in ms, bars) and ACC (in %, line) for each simplified task-rule congruency condition, with 95% confidence interval. by Marcel F. Hinss (14675457)

Subjects:

RTs (in ms, bars) and ACC (in %, line) across different types of task-rule congruency, with 95% confidence interval. by Marcel F. Hinss (14675457)

Subjects:

RTs (in ms, bars) and ACC (in %, line) across all tasks, with 95% confidence interval. by Marcel F. Hinss (14675457)

Subjects:

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

Subjects:

Examples of the different task-rule congruency conditions. by Marcel F. Hinss (14675457)

Subjects:

RTs (in ms, bars) and ACC (in%, line) across blocks, with 95% confidence interval. by Marcel F. Hinss (14675457)

Subjects:

Effect of IPT on growth–WAZ, HAZ, WHZ–from enrollment to ~14 and 24 months of age–intent-to-treat analysis–longitudinal and cross-sectional linear analyses. by Ashenafi Shumey Cherkos (19434556)

Subjects:

Mean value (± SE) of life history parameters of <i>A</i>. <i>glycines</i> exposed to imidacloprid and thiamethoxam. by Aonan Zhang (8933630)

Subjects: